The neuroprotective potential of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis

Gill Webster; Vicky Pearson; Edwin Lim; Nancy Mayo

doi:10.1177/1352458515616527

The neuroprotective potential of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis

Gill Webster, Vicky Pearson, Edwin Lim, Nancy Mayo

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	PP1.27
Pages (from-to)	NP25
Number of pages	1
Journal	Multiple Sclerosis
Volume	21
Issue number	14
DOIs	https://doi.org/10.1177/1352458515616527
Publication status	Published - Dec 2015
Event	MS Research Australia Progress in MS Research Conference - Melbourne, Australia Duration: 29 Oct 2015 → 30 Oct 2015

Keywords

Myeloid-directed
neuroprotection
kynurenine/tryptophan
growth-factors
anti-inflammatory

Access to Document

10.1177/1352458515616527

Cite this

@article{b05a024b51a641b1bef133cb9a211ec3,

title = "The neuroprotective potential of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis",

keywords = "Myeloid-directed, neuroprotection, kynurenine/tryptophan, growth-factors, anti-inflammatory",

author = "Gill Webster and Vicky Pearson and Edwin Lim and Nancy Mayo",

year = "2015",

month = dec,

doi = "10.1177/1352458515616527",

language = "English",

volume = "21",

pages = "NP25",

journal = "Multiple Sclerosis",

issn = "1352-4585",

publisher = "SAGE Publications",

number = "14",

note = "MS Research Australia Progress in MS Research Conference ; Conference date: 29-10-2015 Through 30-10-2015",

}

TY - JOUR

T1 - The neuroprotective potential of MIS416, a myeloid-directed innate immune therapeutic in Phase 2B trial for the treatment of secondary progressive multiple sclerosis

AU - Webster, Gill

AU - Pearson, Vicky

AU - Lim, Edwin

AU - Mayo, Nancy

PY - 2015/12

Y1 - 2015/12

KW - Myeloid-directed

KW - neuroprotection

KW - kynurenine/tryptophan

KW - growth-factors

KW - anti-inflammatory

U2 - 10.1177/1352458515616527

DO - 10.1177/1352458515616527

M3 - Meeting abstract

SN - 1352-4585

VL - 21

SP - NP25

JO - Multiple Sclerosis

JF - Multiple Sclerosis

IS - 14

M1 - PP1.27

T2 - MS Research Australia Progress in MS Research Conference

Y2 - 29 October 2015 through 30 October 2015

ER -